2 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Recruiting 2 |
Follow nirsevimab: new trials by email Literature Review of nirsevimab trials Research Report on nirsevimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| THRIVE - Trial of Passive Humoral RSV Immunity for Value and Effectiveness Nirsevimab (RSV-specific monoclonal antibody) - Respiratory Syncytial Virus (RSV), Respiratory Infection Virus | Phase 4 | Recruiting | Menzies School of Health Research | 1000 | 2026-06-17 | 2026-10-07 |
| Safety of RSV Preventive Monoclonal Antibody Respiratory Syncytial Virus (RSV) Preventive Monoclonal Antibody - Fever, Adverse Event Following Immunisation | Phase 4 | Recruiting | Duke University | 524 | 2025-10-02 | 2026-03-16 |
Fever (1)
Duke University (1) · Menzies School of Health Research (1)
Australia (1) · United States (1)